ROCKET PHARMACEUTICALS, INC.RCKTEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing first-in-class adeno-associated virus (AAV) and lentiviral-based gene therapies for rare, orphan genetic disorders with high unmet medical need. It primarily operates across the U.S. and European markets, with pipeline candidates targeting hematologic, neurological, and pediatric genetic conditions.